FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

422456007: Ranibizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2641602015 Ranibizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2645708017 Ranibizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
374721000195110 ranibizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
193211000077112 ranibizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
2353521000195119 Ranibizumab de Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranibizumab (substance) Is a agent d'anticorps monoclonal false Inferred relationship Some
Ranibizumab (substance) Is a Angiogenesis inhibitor true Inferred relationship Some
Ranibizumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Ranibizumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Angiogenesis inhibitor (disposition) true Inferred relationship Some
Ranibizumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Vascular endothelial growth factor receptor antagonist (disposition) true Inferred relationship Some
Ranibizumab (substance) Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ranibizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ranibizumab (substance) Inferred relationship Some 1
Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ranibizumab (substance) Inferred relationship Some
Uveitis caused by ranibizumab (disorder) Causative agent (attribute) False Ranibizumab (substance) Inferred relationship Some 2
Ranibizumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ranibizumab (substance) Inferred relationship Some 1
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ranibizumab (substance) Inferred relationship Some 1
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ranibizumab (substance) Inferred relationship Some 1
Ranibizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ranibizumab (substance) Inferred relationship Some 1
Ranibizumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ranibizumab (substance) Inferred relationship Some 1
Uveitis caused by ranibizumab (disorder) Causative agent (attribute) True Ranibizumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start